MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • MDS Virtual Congress 2021

    Dissociated longitudinal evolution of limbic serotonergic and striatal dopaminergic and serotonergic pathology in apathetic and non-apathetic patients in early Parkinson’s disease

    S. Prange, E. Metereau, H. Klinger, E. Schmitt, E. Lhommée, A. Bichon, D. Le Bars, A. Maillet, P. Pellissier, S. Meoni, E. Broussolle, A. Castrioto, P. Krack, S. Thobois (Bron, France)

    Objective: To investigate the longitudinal changes in striatal and extra-striatal dopaminergic and serotonergic innervation in apathetic and non-apathetic patients during the five years after the…
  • MDS Virtual Congress 2021

    Cognition-related functional topographies in Parkinson’s disease: Localized loss of the ventral default mode network

    K. Schindlbeck, A. Vo, P. Mattis, K. Villringer, F. Marzinzik, J. Fiebach, D. Eidelberg (Manhasset, USA)

    Objective: We sought to determine whether functional network abnormalities seen in patients with Parkinson’s disease (PD) and cognitive decline reflect the loss of the default…
  • MDS Virtual Congress 2021

    Progression of nigrostriatal dysfunction in Parkinson’s disease: a longitudinal multimodal PET study

    K. Steidel, M. Ruppert, A. Greuel, M. Tahmasian, F. Maier, J. Hammes, T. van Eimeren, L. Timmermann, M. Tittgemeyer, A. Drzezga, D. Pedrosa, C. Eggers (Marburg, Germany)

    Objective: To investigate the longitudinal course of nigrostriatal metabolic and dopaminergic dysfunction and its impact on symptom severity in Parkinson's disease (PD) patients using a…
  • MDS Virtual Congress 2021

    Cognitive-affective syndrome related to cerebellar hypometabolism secondary to Covid-19 infection : a case report

    S. Potel, M. Merceur, P. Méneret, S. Butet, P. Guillemot, G. Silvestre-Beccarel, I. Bonan, F. Le Jeune, M. Vérin (Rennes, France)

    Objective: To describe a novel case of Covid-19-related cognitive affective syndrome with cerebellar hypometabolism and associated neuropathy. Background: Several Covid-19-related neurological diseases have been described, including…
  • MDS Virtual Congress 2021

    VMAT2 availability in Parkinson’s Disease with Rapid Eye Movement Sleep Behaviour Disorder

    M. Valli, SS. Cho, C. Uribe, M. Masellis, R. Chen, A. Mihaescu, A. Strafella (Toronto, Canada)

    Objective: To use [11C]DTBZ PET imaging to explore vesicular monoamine transporter 2 (VMAT2) availability in Parkinson’s disease (PD) with and without rapid eye movement sleep…
  • MDS Virtual Congress 2021

    Widespread loss of presynaptic terminal marker SV2A in early Huntington’s disease.

    A. Delva, L. Michiels, M. Koole, K. van Laere, W. Vandenberghe (Leuven, Belgium)

    Objective: To assess synaptic damage in early stages of Huntington’s disease (HD) in vivo. Background: Synaptic damage has long been suspected to play a major…
  • MDS Virtual Congress 2021

    Comorbid Moyamoya Disease and Parkinson’s disease: A case series

    D. Yoo (Seoul, Republic of Korea)

    Objective: We report the first case series of comorbid Moyamoya disease (MMD) and Parkinson’s disease (PD). Background: MMD is characterized by angiographic findings of bilateral…
  • MDS Virtual Congress 2021

    Clinical variants of PSP: phenotypical convergence and its relationship with the brain glucose metabolism

    G. Martí-Andrés, D. Vállez-García, E. Prieto, L. van Bommel, S. Meles, R. Valentí, R. Kogan, V. Gurvits, M. Riverol, MR. Luquin, KL. Leenders, J. Arbizu (Pamplona, Spain)

    Objective: To evaluate the phenotypical convergence phenomena among a cohort of different PSP variants. We also aimed to evaluate the possible correlations of the regional…
  • MDS Virtual Congress 2021

    Progression of neuroinflammation in patients with isolated REM sleep behavior disorder. A 11C-PK11195 PET study

    A. Baun, K. Stær, A. Iranzo, M. Stokholm, K. østergaard, M. Serradell, M. Otto, K. Svendsen, A. Garrido, D. Vilas, J. Santamaria, A. Møller, C. Gaig, D. Brooks, P. Borghammer, E. Tolosa, N. Pavese (Aarhus, Denmark)

    Objective: The aim of this study was to investigate in vivo the progression of neuroinflammation iRBD patients over a 3-year follow-up. Background: Isolated rapid-eye-movement behaviour…
  • MDS Virtual Congress 2020

    Noradrenergic terminal and locus coeruleus cell loss may be uncoupled in Parkinson’s disease – a PET and MRI multi-modal imaging study

    M. Kinnerup, C. Doppler, E. Farrher, T. Fedorova, J. Schaldemose, K. Knudsen, R. Isamail, A. Hansen, K. Stær, G. Fink, J. Shah, D. Brooks, A. Nahimi, P. Borghammer, M. Sommerauer (Aarhus, Denmark)

    Objective: To assess multimodal imaging of the noradrenergic system: magnetic resonance imaging (MRI) neuromelanin contrast of the locus coeruleus (LC) and noradrenalin transporter density with…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley